When was Resilience founded?

Resilience was founded in 2016.

Where is Resilience located?

Resilience is headquartered in Paris, France.

Where does Resilience rank among its competitors?

Resilience ranks 421st amongst 608 active competitors, of which 69 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was mPharma, which secured an undisclosed amount in Dec, 2025.

Who are the top competitors of Resilience?

Resilience's top competitors include Dedalus, Concert AI and Bioptimus. Among them, mPharma secured the most recent funding round in December, 2025.

Resilience - 2026 Company Profile, Funding & Competitors

Company Details

Provider of biopharmaceutical manufacturing and technology solutions. Features include biologics development and manufacturing, cell & gene therapy manufacturing, sterile fill and finish, drug product manufacturing, device assembly, packaging, and logistics. It provides end-to-end development and manufacturing services for complex medicines, biologics, and cell and gene therapies.

Key Metrics

Founded Year

2016

Location

Paris, France

Stage

Funding Raised

Investors

Seaya

Ranked

421^st among 608 active competitors

Similar Companies

Concert AI & 177 more

View Resilience's full profile

Resilience is a funded company. Resilience has 1 institutional investor.

View details of Resilience's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Resilience include Dedalus, Concert AI and Bioptimus. Here is the list of Top 10 competitors of Resilience, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Dedalus 1982, Milano (Italy), Acquired	Provider of advanced software solutions that enhance healthcare interoperability	$26.9M	ADIA, Tamburi Investment Partners & 8 others	64/100
2nd	Concert AI 2018, Boston (United States), Series C	Provider of AI and real-world data solutions for life sciences	$300M	Sixth Street, Declaration Partners & 4 others	63/100
3rd	Bioptimus 2024, Paris (France), Series A	Developer of AI foundation model to transform biological research	$76M	Sofinnova Partners, Cathay Innovation & 15 others	63/100
4th	Dotmatics 2005, Bishop s Stortford (United Kingdom), Acquired	AI powered scientific data management and workflow automation solutions	$11.3M	Scottish Equity Partners, Insight Partners ... & 4 others	61/100
5th	Greenlight Guru 2013, Indianapolis (United States), Series A	Developer of quality management system software for the medical device industry	$121M	JMI Management, Elevate Ventures	61/100
6th	mPharma 2013, Accra (Ghana), Series D	Provider of pharmacy management services and software for stock management for patients and pharmacies	$95.3M	Novastar Ventures, Citi & 33 others	60/100
7th	MasterControl 1994, Salt Lake City (United States), Late Stage	Developer of software for quality, manufacturing, and asset management solutions	$150M	Sixth Street, Sixth Street Growth	59/100
8th	Health Gorilla 2014, Coral Gables (United States), Series C	Provider of healthcare information network platform to access patient data	$80M	IA Capital Group, Nationwide & 14 others	58/100
9th	Rhapsody 2018, Boston (United States), Acquired	Interoperability solutions accelerating digital health through seamless data exchange and stronger connections	$13.2M	HgCapital Trust, Hg	57/100
10th	Qualio 2012, San Francisco (United States), Series B	Provider of cloud-based quality management software for the life science industry	$63.9M	500 Global, Storm Ventures & 10 others	57/100
421st	Resilience 2016, Paris (France), Funding Raised	Provider of biopharmaceutical manufacturing and technology solutions	-	Seaya	22/100